Background: Clinic attendance, metabolic control, engagement in self-management, and psychological health are suboptimal in young-onset (age of onset <40 years) type 2 diabetes.
Objective: We examined the effectiveness of an enhanced SMS text message–based support and reminder program in improving clinic attendance, metabolic control, engagement in self-management, and psychological health in young-onset type 2 diabetes.
Methods: A 12-month, parallel-arm, randomized controlled trial comparing an enhanced, semipersonalized SMS text message–based intervention (incorporating 1-8 supportive and/or informative text messages per month) against standard care was conducted in a specialized clinic for young adult type 2 diabetes. The primary outcome was maintenance of 100% attendance at scheduled quarterly clinical appointments. Secondary outcomes included (1) metabolic indices, (2) pathology and self-monitored blood glucose (SMBG) data availability, and (3) psychosocial well-being.
Results: A total of 40 participants were randomized, and 32 completed their 12-month study visit. The average participant age was 32.7 (SD 5.1) years, 50% (20/40) were male, and baseline glycated hemoglobin A1c (HbA1c) was 7.3% (SD 1.9%) (56 mmol/mol, SD 20). A higher proportion of the intervention group achieved 100% attendance (12/21, 57%, vs 5/19, 26%, for the control group); Kaplan-Meier analysis demonstrated significantly greater cumulative attendance in the intervention group (P=.04). There were no between-group differences in HbA1c, BMI, lipids, or availability of pathology and SMBG data. Odds of recording an improvement in the Diabetes Empowerment Scale–Short Form score were higher in the intervention group at 6 months (odds ratio [OR] 4.3, 95% CI 1.1-17), with attenuation of this effect at study end (OR 3.1, 95% CI 0.9-11). Program acceptability was high; >90% of participants would recommend the program to new patients.
Conclusions: An enhanced SMS text message–based support and reminder program doubled scheduled clinic attendance rates for patients with young-onset type 2 diabetes. The program was highly acceptable and provided early support for patient empowerment but had no significant effect on measures of metabolic control or self-management.
Trial Registration: Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202); https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373579
Over the past 20 years, young‑onset type 2 diabetes (age of onset <40 years) has emerged as a significant clinical problem. The worldwide prevalence of young‑onset type 2 diabetes more than doubled during the decade spanning 2003 to 2013, and today, well in excess of 60 million young people are living with type 2 diabetes [, ]. This is particularly concerning given the aggressive nature of young-onset type 2 diabetes, with high rates of complications, established premature mortality, and the poorest comparative outcomes [ - ].
Suboptimal clinic attendance and poor engagement in self-management represent significant barriers to improving long-term outcomes [, ]. There is specific evidence that clinic attendance associates with favorable outcomes in young-onset type 2 diabetes; during the landmark Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study of adolescent type 2 diabetes, it was established that participants who attended ≥75% of scheduled lifestyle education sessions achieved significantly greater weight reductions than those who attended less often [ ]. An audit of clinic attendance at a metropolitan, hospital-based diabetes center clearly demonstrated that young adults with type 2 diabetes were the subgroup that had the highest rate of nonattendance; median loss to follow-up time was approximately 4 months [ ]. As each clinical encounter provides an excellent opportunity to review a patient’s understanding of diabetes and its management, convey important messages relating to self-management, adjust pharmacotherapy, perform complications screening, and foster a therapeutic rapport, novel ideas are needed to motivate young adults with type 2 diabetes and encourage more reliable clinic attendance.
In recent years, innovative text messaging interventions have yielded promising results in high-risk groups. The landmark TEXTME study demonstrated that a structured, lifestyle-based SMS text messaging program could improve cardiovascular risk factor management after myocardial infarction . In adolescent medicine, SMS text message interventions have been used to address important issues, including teenage pregnancy and binge drinking of alcohol [ , ]. In the field of diabetes, the SMS4BG study established that an SMS text messaging program could facilitate modest improvement in glycemic control [ ]. However, the SMS4BG study did not specifically examine the impact of the program on clinic attendance, nor did it specifically target individuals with young-onset type 2 diabetes. A study from Hong Kong did identify a benefit of an SMS text message reminder for the attendance rate within a type 2 diabetes population at a primary care clinic [ ]. However, participants in the Hong Kong study had a mean age of 63 years; as a result, the benefit of SMS text message reminders in the young-onset type 2 diabetes setting remains to be established. Overall, young adults with type 2 diabetes have been underrepresented in most clinical studies to date [ ]. Consequently, high-quality evidence to guide management of young-onset type 2 diabetes remains scarce.
It is widely understood that young people are frequent users of information and communications technology. In 2012 and 2017, young adult respondents to our diabetes and technology survey reported the highest rates of mobile phone ownership and a high degree of comfort with the use of technology in diabetes management . Familiarity with SMS text messaging technology as well as its low cost and ready scalability provide a great impetus for an exploration of the utility of SMS text message interventions in the young adult demographic. We hypothesized that an enhanced SMS text message–based support and reminder program would improve clinic attendance, metabolic health, and engagement in diabetes self-management and psychosocial well-being within our young-onset type 2 diabetes cohort. We set out to test this hypothesis in the TEXT2U randomized controlled trial (RCT).
TEXT2U was a parallel group, investigator-blinded, 12-month RCT involving participants with young‑onset type 2 diabetes (age of onset 18-40 years). The primary aim was to assess the effect of an enhanced SMS text message–based support and reminder program on clinic attendance. Secondary aims were to assess (1) metabolic outcomes, (2) diabetes self-management practices as evidenced by availability of self-monitoring of blood glucose (SMBG) data and pathology results, and (3) the psychosocial impact of the intervention as measured by change in validated diabetes-specific questionnaire scores (Problem Areas in Diabetes 5-item Short Form (PAID-5) , Diabetes Empowerment Scale–Short Form (DES-SF) [ ], and Type 2 Diabetes Stigma Assessment Scale (DSAS-2) [ ]). The study was approved by the Sydney Local Health District Ethics Review Committee and registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12618000479202).
Study Setting and Participant Recruitment
The Royal Prince Alfred Hospital (RPAH) Diabetes Centre is a secondary and tertiary referral center that services an ethnically diverse population in metropolitan Sydney, Australia. Individuals were eligible to enter the study if they had an established type 2 diabetes diagnosis, had access to a mobile phone, and were aged 18-40 years at time of enrolment. Individuals with insufficient proficiency in English to read the text messages in the study were excluded. All participants provided written informed consent prior to study entry. Recruitment was performed between March and August 2018.
Block randomization was employed with a standard block size of 4 using a customized, computer-based program. Participants were allocated 1:1 to either the standard care control group or the standard care plus enhanced SMS text message–based support and reminder intervention group. Medical staff delivering patient care were blinded to study group allocation.
Control: Clinic Standard of Care
The control group received our young-onset type 2 diabetes clinic standard of care, which is aligned with and realizes current recommendations for youth and young adults with type 2 diabetes . It includes quarterly follow-up appointments with a diabetes educator and endocrinologist. Glycemic control was assessed via glycated hemoglobin A1c (HbA1c) and capillary-based SMBG results, weight and blood pressure (BP) were measured, and treatment adjustments were made at the discretion of the treating endocrinologist. Dietary review with an accredited dietitian was provided as required. All participants were given a personal blood glucose meter with a starter pack of glucose monitoring strips and a personal lancing device for SMBG. All individuals in the young adult type 2 diabetes clinic are enrolled in the Australian National Diabetes Services Scheme, which provides ongoing access to subsidized glucose testing strips and lancets.
After each clinic visit, participants were provided with details of their next follow-up appointment. A generic SMS text message reminder was sent prior to scheduled appointments via the hospital’s outpatient management system. In the event of a missed clinic appointment, clinic staff made attempts to contact the relevant individual (via telephone and email) to reschedule a makeup appointment.
Intervention: Enhanced SMS Text Message–Based Support and Reminder Program
The enhanced SMS text message–based support and reminder program involved receipt of clinic standard of care as outlined above, plus a structured program of semipersonalized text messages. Message content was individualized on the basis of key baseline characteristics, including gender and smoking status. Message delivery was managed by an automated system developed and programmed by coauthor AT (TextQStream, Python 3.6, using the Pycap 1.02 library). This system was developed previously , and customization was performed in-house for the TEXT2U trial. Computer software was run through the University of Sydney Research Electronic Data Capture (REDCap) system [ ]. Messages to the study participants were sent through a gateway interface over Australian telephone networks at no cost to individual participants. All SMS text messages sent during the study were logged by the system; the study log included the date and time that each message was delivered. All participants received an introductory message in the week following their baseline visit and then two messages per week for the first 2 months of the study. Text message frequency decreased to one message per week during the third month and then one text message per month thereafter. All study messages were sent at random times during standard business hours: Monday to Friday, 9 AM to 5 PM. Instructions on how to opt out of the messaging program were provided.
The SMS text messaging program was developed by a focus group of 10 diabetes specialists associated with the Royal Prince Alfred Hospital Diabetes Centre; adjustments were made following consumer review by young adults with diabetes. In particular, 15 young adults with diabetes (aged 18-40 years), who did not form part of the young adult type 2 diabetes clinic, were asked to complete a brief survey and each provide feedback on different subsets of messages that were to be featured in the study. Program messages were designed to contain a mix of supportive and informative content. Messages were entirely text-based; emojis and multimedia messaging were not incorporated into the program. A personalized appointment reminder was sent to participants in the enhanced SMS group in the week before each follow-up appointment. Examples of program text messages are included in(Table S1).
An option was provided for enhanced SMS group participants to engage with the study team via the study-specific SMS portal. Questions relating to diabetes and its management could be sent directly to the study team at a participant’s convenience. The SMS portal was actively monitored by a research assistant, and all text messages received from participants were reviewed and replied to within 1 business day.
All participants underwent baseline assessment and were asked to attend quarterly follow-up visits for 12 months. Weight, BP, SMBG records, and routine pathology test results were assessed at each study visit. At baseline, all participants completed the Health Literacy Questionnaire . Validated measures of psychosocial status, including the PAID-5 [ ], DES-SF [ ], and DSAS-2 [ ], were self-completed by participants at baseline, 6 months, and 12 months. Participants assigned to the enhanced SMS intervention group were invited to complete an evaluation of the program via a standardized, study-specific questionnaire at the end of the study.
From prior analyses , the median time to clinic dropout associated with our standard care approach in the young-onset type 2 diabetes clinic was 4 months. Previous studies comparing attendance rates in SMS text message reminder vs control interventions have demonstrated odds ratios (ORs) of 1.7-4.3 in favor of text messaging [ ]. Given this information, we estimated that an enhanced SMS text message–based support and reminder system would increase the median time to clinic dropout in our young-onset type 2 diabetes cohort from 4 to 12 months. We determined that a 12-month study with quarterly clinic follow-up for 40 individuals (randomized 1:1 to the intervention and control groups) would have 80% power (α=.05) to enable us to reject the null hypothesis of no difference in loss to follow-up.
The primary outcome was evaluated using the principles of time to event analysis. For secondary outcomes, data collected at each follow-up visit (regardless of whether the visit was attended as scheduled or as a make-up appointment) were considered in the analyses. For those participants who failed to attend a follow-up appointment and did not attend a makeup appointment, missing data were not imputed. Participants were analyzed by original group assignment. Data from descriptive analyses are reported as mean (SD) or n (%) values. Comparisons between groups were made using analysis of variance for continuous variables and Pearson chi-squared tests for categorical variables.
The primary outcome of attendance at all scheduled follow-up appointments was analyzed using a Kaplan-Meier approach. Difference in scheduled follow-up attendance between the intervention and control groups was compared using the log-rank test. In addition to our primary attendance outcome, overall attendance (ie, attendance at scheduled appointments and rescheduled makeup appointments) was assessed.
With respect to secondary outcomes, metabolic indices at 12 months in the control and intervention groups were compared using the independent samples t test. Mean changes (from baseline) for metabolic indices in both the control and intervention groups were evaluated using the paired samples t test. Binary logistic regression analyses were performed to explore differences between the intervention and control groups in the log odds of observing the other secondary outcomes of interest. For the PAID-5, DES-SF, and DSAS-2 analyses, the outcome of interest was positive change in questionnaire score (ie, a score change that would indicate less diabetes distress and stigma or greater self-efficacy). The dependent variable for each model was the outcome of interest, and the independent variables included group assignment, follow-up time, and the interaction between group assignment and follow-up time. A general estimating equations framework was employed to allow within-participant correlations (in the context of repeated measures) to be taken into account. Data collected from participants who attended make-up appointments were considered in secondary outcome analyses. These data were ascribed to the nearest scheduled follow-up appointment.
Statistical analyses were performed using SPSS, version 24.0 (IBM Corporation). All statistical tests were two-tailed and were conducted at the .05 significance level.
Between March and August 2018, 41 patients of the RPAH Diabetes Centre young-onset type 2 diabetes clinic were approached regarding study participation; 40 were enrolled and randomized, and 32 participants completed a 12-month follow-up appointment (, Figure S1). The mean age of the study cohort was 32.7 years, 50% (20/40) of participants were male, mean HbA1c was 7.3% (56 mmol/mol) and mean duration of diabetes at the time of study entry was 6.4 years. Baseline characteristics were similar in the enhanced SMS and standard of care groups ( ). Notably, there were no between-group differences in glycemic control, diabetic pharmacotherapy use, or health literacy measures.
|Intervention group (n=21)||Control group (n=19)|
|Male gender, n (%)||10 (48)||10 (53)||.99|
|Age (years), mean (SD)||33.0 (5.8)||32.4 (4.4)||.71|
|Ethnic background, n (%)||.38|
|East/Southeast Asian||8 (38)||3 (16)|
|Subcontinental||5 (24)||7 (37)|
|European||4 (19)||6 (32)|
|Other||4 (19)||3 (16)|
|Nonsmoker, n (%)||11 (52)||14 (74)||.17|
|Education, n (%)||.14|
|TAFEa/university||19 (91)||13 (68)|
|High school||2 (10)||5 (26)|
|Not disclosed||0 (0)||1 (5)|
|Duration of diabetes (years), mean (SD)||7.6 (6.2)||5.0 (5.9)||.18|
|Diabetes treatment, n (%)||.32|
|Diet alone||2 (10)||5 (26)|
|Oral hypoglycemic medication||14 (67)||8 (42)|
|Insulin oral hypoglycemic agent||5 (24)||6 (32)|
|HbA1cb (%), mean (SD)||7.2 (1.6)||7.3 (2.1)|
|HbA1c range (%), n (%)||.94|
|<6.5||9 (43)||9 (47)|
|6.5-8.5||8 (38)||8 (42)|
|>8.5||4 (19)||2 (10)|
|BMI (kg/m2), mean (SD)||31.8 (8.6)||31.6 (5.1)||.92|
|Systolic blood pressure (mm Hg), mean (SD)||118 (11)||118 (9)||.94|
|Antihypertensive medication, n (%)||7 (33)||4 (21)||.39|
|Total cholesterol (mmol/L), mean (SD)||4.6 (1.2)||4.7 (0.9)||.87|
|Triglycerides (mmol/L), mean (SD)||2.1 (1.6)||2.7 (2.1)||.32|
|Lipid-lowering medication, n (%)||6 (29)||7 (37)||.58|
|eGFRc (mL/min/1.73 m2), mean (SD)||111 (19)||112 (13)||.88|
|Abnormal UACRd, n (%)||8 (38)||6 (32)||.67|
|HLQe Scale 2 scoref, mean (SD)||3.1 (0.3)||3.3 (0.5)||.14|
|HLQ Scale 6 scoreg, mean (SD)||4.0 (0.7)||4.1 (0.6)||.40|
aTAFE: Technical and Further Education.
bHbA1c: glycated hemoglobin A1c.
ceGFR: estimated glomerular filtration rate.
dUACR: urine albumin to creatinine ratio.
eHLQ: Health Literacy Questionnaire.
fHLQ Scale 2 score reflects an individual’s confidence in their knowledge to manage their health. Higher scores equate to higher confidence levels.
gHLQ Scale 6 score reflects an individual’s confidence in their ability to actively engage with health care providers. Higher scores equate to higher confidence levels.
Primary Endpoint: 100% Attendance at Scheduled Follow-up Appointments
The proportion of participants who maintained 100% attendance at scheduled clinic appointments for successive follow-up appointments is presented in. At 12 months, more participants in the enhanced SMS intervention group achieved 100% attendance at scheduled clinic appointments (12/21, 57%, vs 5/19, 26%). A statistically significant difference between the intervention and control groups was observed with respect to 100% attendance ( , ; log-rank P=.04).
|Group||Value, n (%)|
|Baseline||3 months||6 months||9 months||12 months|
|Intervention (n=21)||21 (100)||17 (81)||16 (76)||12 (57)||12 (57)|
|Control (n=19)||19 (100)||13 (68)||8 (42)||6 (32)||5 (26)|
Overall Clinic Attendance
The proportion of clinic appointments that were attended as scheduled was greater in the intervention group than in the control group (64/84, 76%, vs 44/76, 58%;, Table S2). It was possible to boost clinic attendance to 80% in both the intervention and control groups, but only after proactive contact by administrative staff and rescheduling of missed appointments ( , Table S2). The requirement for this extra administrative burden was lower in the intervention group; 18% fewer rescheduling interventions were necessary in this group.
Clinical Metabolic Outcomes
Key end-of-study metabolic indices for the intervention and control groups are presented in. For those with 12-month follow-up data (20/21 intervention and 15/19 control, respectively), there was no difference in mean HbA1c between groups (mean 7.1%, SD 1.1%, for the intervention group vs mean 6.6%, SD 1.7%, for the control group; P=.37). For both groups, clinic attendance was associated with glycemic stability; there was no statistically significant change in mean 12-month HbA1c (relative to baseline) for either the intervention or control group ( , Table S3). If the analysis was restricted to those with 100% attendance, the change in HbA1c from baseline to study end was –0.58% (95% CI –1.70 to 0.59) (intervention) and –0.18% (95% CI –0.46 to 0.10) (control). Although the physicians working in the young adult type 2 diabetes clinic ensure that all patients have access to valid prescriptions for their diabetic pharmacotherapy at each clinic visit, absolute adherence to pharmacotherapy was not actively assessed during this study. Analogously to HbA1c, there were no statistically significant between-group differences with respect to BMI, total cholesterol, or triglycerides.
|Metabolic index||Values, mean (SD)||P value|
|Intervention group||Control group||Mean difference (95% CI)|
|HbA1ca (%)||7.1 (1.1)||6.6 (1.7)||0.4 (–0.5 to +1.4)||.37|
|BMIb (kg/m2)||30.4 (8.4)||31.8 (5.8)||–1.5 (–6.7 to +3.8)||.57|
|Total cholesterolc (mmol/L)||4.6 (1.4)||4.7 (0.9)||–0.1 (–1.0 to +0.7)||.75|
|Triglyceridesc (mmol/L)||2.1 (1.7)||2.9 (4.1)||–0.8 (–3.3 to +1.6)||.50|
aHbA1c: glycated hemoglobin A1c. 12-month HbA1c data were available for 20/21 intervention group participants and 15/19 control group participants.
b12-month BMI data were available for 18/21 intervention group participants and 15/19 control group participants.
c12-month total cholesterol and triglyceride data were available for 20/21 intervention group participants and 14/19 control group participants.
Diabetes Self-management Practices
Overall, SMBG data were available at 40% of the intervention group’s appointments, versus 37% of the control group’s appointments (, Figure S2). The corresponding figures for the pathology results were 69% and 66%, respectively ( , Figure S3). Binary logistic regression modeling revealed no between-group differences with respect to availability of SMBG or pathology results at follow‑up. The ORs for availability of SMBG data and pathology results in the intervention group were 1.2 (95% CI 0.4-3.1) and 1.1 (95% CI 0.4-3.2), respectively ( , Panels A and B).
Psychosocial Impact (Baseline Versus 6 Months and 12 Months)
An overview of the PAID-5, DES-SF, and DSAS-2 scores for the study cohort is presented in(Table S4). Analysis of the changes in DES‑SF score at 6 months revealed a significant between-group difference favoring the intervention ( , Table S4); 68% (13/19) of members of the intervention group recorded a favorable change in DES-SF score at 6 months, versus 31% (5/16) in the control group (P=.03). At 12 months, this difference was no longer statistically significant. In the analyses of the changes in PAID-5 and DSAS-2 scores, there were no significant between-group differences for either of the scores at 6 or 12 months ( , Table S4).
Binary logistic regression modeling revealed no evidence of a difference in the odds of recording a positive change in PAID‑5 or DSAS-2 scores for the intervention and control groups (, panels C and E). Although not statistically significant at 12 months, the OR for positive change in DES-SF score at 6 months (4.3, 95% CI 1.1‑17.3) was significantly higher for those who participated in the enhanced SMS text messaging program ( , panel D).
Evaluation of the Enhanced SMS Text Message–Based Support and Reminder Program
Of the 21 participants randomized to the enhanced SMS text messaging intervention group, 20 received all study text messages; 1 participant asked to stop receiving text messages midstudy. Of the 21 participants randomized to the enhanced SMS group, 11 chose to use the study-specific SMS portal (, Table S5). The median number of messages sent by participants was 3 (range 1-29). Analysis of message content revealed that 28% (21/74) of the messages sent by participants expressed gratitude (for a message received or a service provided by the clinic), 25% (19/74) of messages directed a diabetes-specific question to the study team or sought clarification regarding some aspect of diabetes management, and 24% (18/74) of messages were concerned with rescheduling a clinic appointment. With respect to diabetes-related questions, participants inquired about a variety of different issues, including management of hypoglycemia, dietary recommendations for people with type 2 diabetes, guidelines for dental follow-up, diabetic foot care, and the effects of stress and alcohol on blood glucose.
Following study completion, 16/21 (76%) of the SMS group participants provided feedback on their experience (, Table S6). Of the 21 SMS group participants, 5 did not attend their scheduled 12-month follow-up clinic visit (or a makeup appointment for their missed clinic visit); therefore, these study participants did not provide feedback on the program. Those who did not provide feedback on the program were slightly younger (age 29.2 years, SD 6.1 years, vs 34.2 years, SD 5.4 years) and heavier (40.4 kg/m2, SD 11.3 kg/m2, vs 29.1 kg/m2, SD 5.7 kg/m2) with slightly lower baseline HbA1c (6.8%, SD 0.9%, vs 7.4%, SD 1.8%).
All respondents to the end-of-study survey found that the study messages were easy to understand, supportive in nature, and delivered at appropriate times. In addition, 94% (15/16) of respondents reported that the messages contained practical information for people with diabetes and motivated them to think about their diabetes management. Overall, 94% (15/16) of respondents indicated that they would recommend the program to all new patients of the clinic.
The TEXT2U study established that an enhanced SMS text message–based support and reminder program was effective at improving scheduled clinic attendance rates. Relative to the control group, the enhanced SMS text messaging intervention more than doubled the number of participants who attended all follow-up appointments. For those who attended all scheduled clinic appointments, the overall finding was stability of HbA1c, weight, and lipid profiles during the 12-month study period. With respect to the psychological impact of the intervention, we observed an improvement in psychosocial self-efficacy; a statistically significant favorable change in DES-SF score was observed at 6 months. However, we did not observe any between-group differences in measures of diabetes-specific distress nor in measures of perceived and experienced stigma related to living with type 2 diabetes. Overall, the enhanced SMS text message–based support and reminder program was well received and facilitated between-visit engagement with the health care team; >90% of respondents to the end-of-study survey said they would recommend the program to new patients. Although the completion rate of the end-of-study survey was 76% (5 participants did not attend a 12-month study visit), it remains reassuring that >70% of all SMS program recipients found utility in the SMS text messaging program employed in this study. In this setting, one anticipates that the majority of future consumers of TEXT2U will derive benefit from participation in the program.
Research in Context
Our findings align with existing evidence that indicates text messaging interventions are an effective method to aid in the modification of health behaviors [, ]. In a diabetes-specific context, the Sweet Talk RCT [ ] identified that a text messaging system to support young people with type 1 diabetes was successful in improving measures of diabetes self-efficacy but not glycemic control. It is well recognized that the needs of youth with type 1 diabetes differ from those with type 2 diabetes [ ]. Consequently, it is informative that this is the first study to show clear benefit of an enhanced SMS text message–based intervention over and above simple SMS reminder text messaging on clinic attendance in young-onset type 2 diabetes.
The issues of suboptimal clinic attendance and loss to follow-up are important problems in clinical practice. Maintaining clinic attendance is particularly important during young adulthood given the increased risk of diabetes complications  and the competing demands of family, work, study, and socializing, which interfere with maintenance of optimal care. Recurrent nonattendance prevents timely identification of changes in an individual’s health status and eliminates the opportunity for diabetes complications screening, early intervention, and ongoing education; moreover, it hinders the development of a therapeutic relationship [ ]. Various strategies, ranging from written, verbal, and electronic reminders to expensive case management approaches, have been used by health service providers in an attempt to improve clinic attendance and patient outcomes [ , ]. This study adds to the literature by demonstrating that a low-cost, enhanced SMS text message–based intervention is effective at improving clinic attendance over and above a standard SMS appointment reminder system for those with young-onset type 2 diabetes, a cohort that is arguably at greatest risk for poor diabetes outcomes.
Nevertheless, maintenance of optimal clinic attendance remained a significant challenge, with just over one half of the enhanced SMS group and one-quarter of the control group recording a 100% attendance record. The factors that influence clinic nonattendance in youth with type 2 diabetes are poorly understood, likely to be complex, and an important area for further study.
In addition to adverse effects for the individual, nonattendance reduces clinic efficiency and places a significant burden on administrative staff, who are required to contact nonattenders and reschedule make-up appointments . Notably, the enhanced SMS text messaging intervention resulted in improved clinic attendance rate without additional administrative burden. Overall clinic attendance rates were boosted to 80% in both groups; however, with additional administrative intervention to contact patients after missed appointments and then reschedule makeup appointments, this requirement was much higher for the control group. In a resource-constrained setting, it is highly likely that youth who miss clinic appointments will be lost to follow-up and therefore at increased risk of poor long-term outcomes. Moving forward, in-built automation of this program will allow the intervention to be scaled with minimal demand on clinic resources. Although a formal cost-benefit analysis was not undertaken, the relatively low cost of SMS text messaging ensures that this program is not prohibitively expensive.
It is well accepted that improving engagement of patients with their own health care can improve outcomes, and the concept of an informed and empowered patient is now central to many models of care [- ]. The DES-SF measures diabetes self-efficacy across three main domains: (1) managing psychosocial aspects of diabetes care, (2) assessing dissatisfaction and readiness to change, and (3) setting and achieving goals [ ]. For those who attended follow-up appointments in our study, we observed a more favorable pattern of response with respect to serial DES‑SF scores in the intervention group. Conceivably, delivery of supportive text messages and the opportunity to clarify queries by SMS text messaging between clinic visits in our study facilitated an increased sense of empowerment. Furthermore, incorporation of knowledge-based messages allowed important clinical information (including dietary and lifestyle recommendations) to be reinforced outside the clinic setting. This is particularly relevant given that postconsultation retention of medical information is poor [ ].
The lack of a statistically significant improvement in DES-SF score at 12 months may indicate that the support provided by the enhanced SMS text messaging intervention has limited durability or that there may be a threshold to any improvement seen. Furthermore, we did not demonstrate improvement in measures of distress or stigma; plausibly, these more negative psychological elements respond best to in-person encounters and are not amenable to a text-based intervention. Although diabetes empowerment was supported by the enhanced SMS text message–based intervention, we did not see improvement in objective measures of self-care as evidenced by the availability of the SMBG/pathology results.
Although the intervention increased scheduled clinic attendance, we did not observe a difference in mean HbA1c, weight, or lipids between the intervention and control groups at study completion. For the most part, this is unsurprising given that the overall attendance (ie, scheduled attendance plus attendance at makeup appointments) was equal in both study arms. Irrespective of whether a participant attended a scheduled or makeup appointment, those who attended were afforded the same opportunity to have their management adjusted by the treating clinician. Nonetheless, stability of glycemia, close to target HbA1c, over 12 months of follow-up is not an insignificant achievement. The TODAY study clearly demonstrated that many adolescents with type 2 diabetes struggle to maintain glycemic control despite comprehensive care in a well-supervised setting .
The age of the study cohort and their familiarity with text messaging allowed for immediate engagement with the SMS text messaging program; individuals were not hampered by a learning curve in deriving benefit from study participation. In designing this study, we were mindful of the need to avoid overwhelming participants with too many messages; prevention of participant withdrawal due to message fatigue was an important consideration. In previous studies of SMS interventions, investigators regularly sent participants multiple text messages every week. The length of most previous studies has been comparatively short (usually <6 months), and participant attrition due to message fatigue in the short term is less likely. Given our 12-month study duration, a conscious decision was made to taper message frequency over the course of the study. Certainly, there is evidence to suggest that text messaging interventions with a tapering frequency have higher efficacy . Personalization of the text messages ensured that the messages received by each participant were relevant to their personal circumstances, and the intervention had high acceptability. Feedback revealed that 88% of participants felt they had received an appropriate number of messages and 100% felt they received messages at appropriate times. Of the 21 enhanced SMS text messaging program participants, 20 opted to receive all study text messages; study message fatigue was not a significant issue.
There are several limitations of this study. First, it should be noted that our study was powered to detect a difference in clinic attendance but not to detect small differences in secondary outcomes. Secondly, our study was conducted at a secondary and tertiary referral center with a modest number of participants; testing in other settings will be required to confirm generalizability. In addition, our study population comprised a well-educated cohort (80% had attended, or were attending, Technical and Further Education [TAFE] or university). Although the message program employed plain language, it would be worthwhile to consider further testing in groups with lower literacy levels to establish better generalizability of the results. Furthermore, we specifically focused on the younger demographic; therefore, applicability in older age groups remains uncertain. Although all study participants had sufficient English proficiency, given our multicultural population, provision of the program in a participant’s native language may well have resulted in greater engagement. By design, it was not possible to blind both participants and treating clinicians in this study. However, blinding of treating clinicians and the use of an objectively measured primary endpoint were important aspects of the study design that help to mitigate observer bias.
In young-onset type 2 diabetes, a low-cost, automated, enhanced SMS text message–based support and reminder system improved scheduled clinic attendance and diabetes self-efficacy over 12 months of follow-up. These achievements were made with high acceptability and low administrative burden. This text-based intervention has the potential to have substantial impact on the care of youth with type 2 diabetes at an especially vulnerable time of life.
This study was supported by an Australian Federal Government Medical Research Future Fund Rapid Applied Research Translation Grant. TM was supported by an Australian Postgraduate Research Scholarship. Elements of this study were presented in abstract form at the Australasian Diabetes Congress, Sydney, Australia, August 21-23, 2019.
TM was involved in the study design; contributed to data acquisition, analysis, and interpretation; and drafted the manuscript. MC and MM assisted in the acquisition of data and provided critical review of the manuscript. MDS contributed to the statistical analysis and critical review of the manuscript. SMT, TW, and JW were involved in the study design, contributed to data analysis and interpretation, and provided critical review of the manuscript. AT and CC were involved in the study design, provided technical support, contributed to analysis and interpretation of data, and provided critical review of the manuscript. All authors approved the manuscript for submission. TM is the guarantor of this work and, as such, had access to all study data and takes responsibility for data integrity and accuracy of the analyses.
Conflicts of Interest
Examples of text messages included in the TEXT2U study.DOC File , 28 KB
Enrollment and participant flow in the TEXT2U randomized controlled trial.DOC File , 75 KB
Overall attendance patterns for the intervention and control groups of the TEXT2U study.DOC File , 32 KB
Mean change in selected metabolic indices (95% CI) after 12 months for the intervention and control groups of the TEXT2U study.DOC File , 37 KB
Proportion of participants with SMBG data available at clinic study visits.DOC File , 43 KB
Proportion of participants with pathology data available at clinic study visits.DOC File , 44 KB
Changes in validated measures of psychosocial status throughout the study.DOC File , 37 KB
Overview of participant utilization of the optional SMS portal.DOC File , 35 KB
Utility and acceptability of the enhanced SMS program to the intervention participants.DOC File , 36 KB
CONSORT-eHEALTH checklist (V 1.6.1).PDF File (Adobe PDF File), 1136 KB
- Diabetes Atlas, 2nd Edition. International Diabetes Federation. URL: https://diabetesatlas.org/en/resources/ [accessed 2021-09-24]
- Diabetes Atlas, 6th Edition. International Diabetes Federation. URL: https://diabetesatlas.org/en/resources/ [accessed 2021-09-24]
- Dabelea D, Stafford JM, Mayer-Davis EJ, D'Agostino R, Dolan L, Imperatore G, SEARCH for Diabetes in Youth Research Group. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 2017 Feb 28;317(8):825-835 [FREE Full text] [CrossRef] [Medline]
- Constantino MI, Molyneaux L, Limacher-Gisler F, Al-Saeed A, Luo C, Wu T, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013 Dec;36(12):3863-3869 [FREE Full text] [CrossRef] [Medline]
- Al-Saeed AH, Constantino MI, Molyneaux L, D'Souza M, Limacher-Gisler F, Luo C, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care 2016 May;39(5):823-829. [CrossRef] [Medline]
- Middleton TL, Constantino MI, Molyneaux L, D'Souza M, Twigg SM, Wu T, et al. Young-onset type 2 diabetes and younger current age: increased susceptibility to retinopathy in contrast to other complications. Diabet Med 2020 Jun;37(6):991-999 [FREE Full text] [CrossRef] [Medline]
- Schectman JM, Schorling JB, Voss JD. Appointment adherence and disparities in outcomes among patients with diabetes. J Gen Intern Med 2008 Oct;23(10):1685-1687 [FREE Full text] [CrossRef] [Medline]
- Fisher E, Lazar L, Shalitin S, Yackobovitch-Gavan M, de Vries L, Oron T, et al. Association between glycemic control and clinic attendance in emerging adults with type 1 diabetes: a tertiary center experience. J Diabetes Res 2018;2018:9572817 [FREE Full text] [CrossRef] [Medline]
- Berkowitz RI, Marcus MD, Anderson BJ, Delahanty L, Grover N, Kriska A, TODAY Study Group. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 2018 Mar;19(2):191-198 [FREE Full text] [CrossRef] [Medline]
- Griffiths C, Brooks B, Landy L, Shi Y, Gauld A, Constantino M, et al. Young onset type 2 diabetes: out of touch and out of time. Poster. 2016 Presented at: Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting; August 24-26, 2016; Gold Coast, Australia p. 24-26 URL: http://ads-adea-2016.m.asnevents.com.au/schedule/session/9237/abstract/36455
- Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015;314(12):1255-1263. [CrossRef] [Medline]
- Devine S, Leeds C, Shlay JC, Leytem A, Beum R, Bull S. Methods to assess youth engagement in a text messaging supplement to an effective teen pregnancy program. J Biomed Inform 2015 Aug;56:379-386 [FREE Full text] [CrossRef] [Medline]
- Suffoletto B, Kristan J, Chung T, Jeong K, Fabio A, Monti P, et al. An interactive text message intervention to reduce binge drinking in young adults: a randomized controlled trial with 9‑month outcomes. PLoS One 2015;10(11):e0142877 [FREE Full text] [CrossRef] [Medline]
- Dobson R, Whittaker R, Jiang Y, Maddison R, Shepherd M, McNamara C, et al. Effectiveness of text message based, diabetes self management support programme (SMS4BG): two arm, parallel randomised controlled trial. BMJ 2018 May 17;361:k1959 [FREE Full text] [CrossRef] [Medline]
- Dao MC, Fu SN, Wong CKH, Luk W. Use of short message service (SMS) reminders to improve the attendance rate of diabetes-related multidisciplinary services in a primary care clinic a randomized controlled trial. Research Square Preprint posted online on November 2, 2019 [FREE Full text] [CrossRef]
- Ke C, Shah BR, Luk AO, Di Ruggiero E, Chan JCN. Cardiovascular outcomes trials in type 2 diabetes: time to include young adults. Diabetes Obes Metab 2020 Jan;22(1):3-5. [CrossRef] [Medline]
- Middleton TL, Constantino MI, Molyneaux L, AlMogbel T, McGill M, Yue DK, et al. Secular trends in information communications technology: access, use, and attitudes of young and older patients with diabetes. Diabetes Spectr 2020 Feb;33(1):66-73. [CrossRef] [Medline]
- McGuire BE, Morrison TG, Hermanns N, Skovlund S, Eldrup E, Gagliardino J, et al. Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia 2010 Jan;53(1):66-69. [CrossRef] [Medline]
- Anderson RM, Fitzgerald JT, Gruppen LD, Funnell MM, Oh MS. The Diabetes Empowerment Scale-Short Form (DES-SF). Diabetes Care 2003 May;26(5):1641-1642. [Medline]
- Browne JL, Ventura AD, Mosely K, Speight J. Measuring the stigma surrounding type 2 diabetes: development and validation of the type 2 Diabetes Stigma Assessment Scale (DSAS-2). Diabetes Care 2016 Dec;39(12):2141-2148. [CrossRef] [Medline]
- Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association. Diabetes Care 2018 Dec;41(12):2648-2668 [FREE Full text] [CrossRef] [Medline]
- Stevenson J, Campbell KL, Brown M, Craig J, Howard K, Howell M, et al. Targeted, structured text messaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis (KIDNEYTEXT): study protocol for a randomised controlled trial. BMJ Open 2019 May 05;9(5):e023545 [FREE Full text] [CrossRef] [Medline]
- Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, REDCap Consortium. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 2019 Jul;95:103208 [FREE Full text] [CrossRef] [Medline]
- Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ). BMC Public Health 2013 Jul 16;13:658 [FREE Full text] [CrossRef] [Medline]
- Lin H, Wu X. Intervention strategies for improving patient adherence to follow-up in the era of mobile information technology: a systematic review and meta-analysis. PLoS One 2014;9(8):e104266 [FREE Full text] [CrossRef] [Medline]
- Franklin VL, Waller A, Pagliari C, Greene SA. A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes. Diabet Med 2006 Dec;23(12):1332-1338. [CrossRef] [Medline]
- Zeitler P, Arslanian S, Fu J, Pinhas-Hamiel O, Reinehr T, Tandon N, et al. ISPAD Clinical Practice Consensus Guidelines 2018: type 2 diabetes mellitus in youth. Pediatr Diabetes 2018 Oct;19 Suppl 27:28-46. [CrossRef] [Medline]
- Kelley JM, Kraft-Todd G, Schapira L, Kossowsky J, Riess H. The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2014;9(4):e94207 [FREE Full text] [CrossRef] [Medline]
- Nuti L, Turkcan A, Lawley MA, Zhang L, Sands L, McComb S. The impact of interventions on appointment and clinical outcomes for individuals with diabetes: a systematic review. BMC Health Serv Res 2015 Sep 02;15:355 [FREE Full text] [CrossRef] [Medline]
- Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006 Jul 26;296(4):427-440. [CrossRef] [Medline]
- Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med 1998 Nov;15 Suppl 3:S14-S24. [CrossRef] [Medline]
- Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985 Apr;102(4):520-528. [Medline]
- Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999 Sep;49(5):651-661. [Medline]
- Hibbard JH. Engaging health care consumers to improve the quality of care. Med Care 2003 Jan;41(1 Suppl):I61-I70. [CrossRef] [Medline]
- Kessels RPC. Patients' memory for medical information. J R Soc Med 2003 May;96(5):219-222 [FREE Full text] [Medline]
- TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012 Jun 14;366(24):2247-2256 [FREE Full text] [CrossRef] [Medline]
- Head KJ, Noar SM, Iannarino NT, Grant HN. Efficacy of text messaging-based interventions for health promotion: a meta-analysis. Soc Sci Med 2013 Nov;97:41-48. [CrossRef] [Medline]
|BP: blood pressure|
|DES-SF: Diabetes Empowerment Scale–Short Form|
|DSAS-2: Type 2 Diabetes Stigma Assessment Scale|
|HbA1c: hemoglobin A1c|
|OR: odds ratio|
|PAID-5: Problem Areas in Diabetes 5-item Short Form|
|RCT: randomized controlled trial|
|REDCap: Research Electronic Data Capture|
|RPAH: Royal Prince Alfred Hospital|
|SMBG: self-monitoring of blood glucose|
|TAFE: Technical and Further Education|
|TODAY: Treatment Options for Type 2 Diabetes in Adolescents and Youth|
Edited by R Kukafka; submitted 19.01.21; peer-reviewed by N Allen, E Villalba-Mora, K Rawlings; comments to author 10.05.21; revised version received 24.06.21; accepted 21.07.21; published 21.10.21Copyright
©Timothy Middleton, Maria Constantino, Margaret McGill, Mario D'Souza, Stephen M Twigg, Ted Wu, Aravinda Thiagalingam, Clara Chow, Jencia Wong. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 21.10.2021.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.